摘要
围手术期止血功能的评估有助于发现潜在的出血性疾病并降低其出血风险。通常情况下,术前止血功能评估应基于病史采集、体检以及进一步的实验室检查。对于已知出血性疾病以及接受抗凝治疗的患者,应充分评估其围手术期出血以及血栓栓塞风险,制订个体化的围手术期处理措施。
Preoperative assessment ofhemostasis is greatly helpful for identifying patients with unknown bleeding disease and predicting bleeding risk associated with surgery or invasive procedures. A recommended approach should combine the information from the bleeding history, the physical examination and the appropriate laboratory tests of hemostasis with the inherent bleeding risk of the planned surgery. The management of patients who are receiving antithrombotic therapy and require surgery is always a challenging clinical problem. Balancing bleeding risk and thromboembolic risk in the periprocedural period is of most importance for making an individualized management strategy.
作者
朱铁楠
ZHU Tie-nan.(Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730 Beijing, China)
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2017年第2期108-112,共5页
Chinese Journal of Practical Internal Medicine
关键词
手术
出血性疾病
抗凝治疗
抗血小板治疗
surgery
bleeding disease
anticoagulation
antiplatelet therapy.
作者简介
朱铁楠，主任医师，北京协和医院血液科副教授、硕士生导师。兼任北京医学会血栓与止血分会委员，中国微循环学会周围血管疾病专业委员会中青年委员，北京医学会血液分会工作秘书。通信作者：朱铁楠，电子信箱：zhutn@pumch．cn
